UNSPSC 51124300: Antiarrythmic quinolines

This classification denotes aromatic heterocyclic structures based on C9H7N, substances called quinolines, that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC QUINOLINES.

UNSPSC 51124300 Antiarrhythmic quinolines, a Class code, covers emergency and critical-care cardiac medications supplied to state and local health agencies, fire departments, and cooperative purchasing alliances. State and local governments buy these medications primarily for emergency medical services (EMS) and hospital use, typically through sealed competitive bidding or cooperative purchasing frameworks. The issuing bodies include city purchasing departments managing fire-rescue operations, state health agencies coordinating pharmacy benefit programs, and multistate cooperative purchasing alliances distributing pharmaceuticals across member jurisdictions. Recent activity reflects sourcing of specific branded antiarrhythmics and generic equivalents in quantities ranging from hundreds to thousands of units annually, with typical requirements including firm pricing, expiration-date guarantees of nine months or longer, rapid delivery (ten calendar days or less), and full compliance with FDA regulations, cGMP certification, and DSCSA supply-chain security standards.

Geographic activity centers on Florida and the Upper Midwest, with additional reach across multistate cooperative memberships. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications (due April 8, 2026, estimated value $40,000) supplying Tampa Fire Rescue with specific medication line items including adenosine and diltiazem vials; the solicitation carried a 5 percent SLBE bid discount and required comprehensive WCAG 2.2 accessibility and OSHA safety documentation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota's Department of Administration, issued RFP S1070000015802 (due March 26, 2026) establishing multiple-award contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson across participating state and local facilities in Minnesota, Oregon, and other member jurisdictions. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs, signaling future formal procurement activity but carrying no immediate award value or timeline.